You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 27, 2026

Bentoquatam - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for bentoquatam and what is the scope of freedom to operate?

Bentoquatam is the generic ingredient in one branded drug marketed by Stand Homeopath and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Summary for bentoquatam
US Patents:0
Tradenames:1
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 10
DailyMed Link:bentoquatam at DailyMed

US Patents and Regulatory Information for bentoquatam

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Stand Homeopath IVY BLOCK bentoquatam LOTION;TOPICAL 020532-001 Aug 26, 1996 OTC Yes Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Market Analysis and Financial Outlook for Bentoquatam

Last updated: February 15, 2026

Overview

Bentoquatam is a topical skin protectant primarily used for preventing and reducing damage from sun exposure and chemical contact. Its dominant application involves sunscreens and chemical barrier products. Despite its niche market, bentoquatam's stability in regulatory approval and manufacturing supports a consistent revenue stream for licensed manufacturers.

Market Dynamics

Industry Role

Bentoquatam functions as a physical skin barrier agent, blocking ultraviolet radiation and chemical irritants. The largest user base lies within the topical protective agents segment, particularly in sunscreens and industrial chemical protective formulations.

Market Drivers

  • Increased sun exposure awareness: Rising skin cancer incidences propel demand for effective sun protection products. The American Cancer Society reports that over 9,500 skin cancers are diagnosed daily in the U.S. (2022).
  • Regulatory standards: Agencies like the FDA set requirements for sun protection factors and chemical safety, favoring barrier agents like bentoquatam.
  • Industrial safety regulations: OSHA mandates protective measures for workers handling irritants, with bentoquatam included in some occupational skin protection formulations.
  • Consumer preferences: Growing demand for chemical-free, natural sun barriers benefits bentoquatam, especially as an inorganic/physical agent.

Market Challenges

  • Limited product differentiation: Bentoquatam's safety profile is well-established, but its market share remains confined among barrier agents.
  • Competitive landscape: Synthetic chemical filters such as oxybenzone and avobenzone dominate sunscreen formulations, with bentoquatam's niche being smaller and more specialized.
  • Regulatory restrictions: Regulatory scrutiny on certain chemicals potentially impacts formulations containing bentoquatam, though it has not faced recent bans.

Market Size and Forecast

Globally, sunscreens alone represented a market valued at approximately USD 10 billion in 2021, projected to grow at 5% annually until 2027 [1]. While bentoquatam is not a primary active in over-the-counter (OTC) sunscreens, it remains a component primarily in formulations marketed for chemical protection and industrial safety.

Estimating its standalone market value involves considering:

  • The fraction of products containing bentoquatam, estimated at less than 10% of the overall sunscreen market.
  • Their average price point, typically USD 10-15 per product.

The bentoquatam market thus offers an estimated revenue of USD 50-100 million globally, primarily driven by industrial and occupational safety markets in North America and Europe.

Financial Trajectory

Revenue Stability and Growth

  • Stable demand: Mid- to long-term contracts with industrial clients and stable OTC sales underpin consistent revenues.
  • Market expansion potential: Entry into emerging markets where occupational protections are increasing offers growth avenues.
  • Innovation and formulation development: Incorporating bentoquatam into new products can expand application scopes.

Cost Factors

  • Manufacturing costs are driven by raw material procurement, typically quartz or silica-based compounds, with stable prices projected.
  • Regulatory compliance costs are moderate, given the established safety record of bentoquatam.

Key Players and Licensing

Major producers such as BASF and proprietary formulators license or produce bentoquatam in specific regions. Licensing agreements influence market expansion and revenue sharing.

Regulatory Landscape

The FDA classifies bentoquatam as a Generally Recognized As Safe (GRAS) substance, with specific permissible concentrations. European countries regulate it under cosmetic and chemical safety directives, with ongoing reviews influencing future market access.

Conclusion

While a niche product, bentoquatam maintains a steady financial trajectory, driven by industrial applications and consumer safety demands. Market growth hinges on expanded applications, regulatory clarity, and penetration into emerging markets.


Key Takeaways

  • Bentoquatam is a skin protectant used mainly in occupational protection and specialty formulations.
  • The global market is estimated at USD 50-100 million, with stable revenues supported by industrial contracts.
  • Growth prospects depend on market expansion, new product formulations, and regulatory changes.
  • Competition from chemical sunscreen agents constrains market share; barriers include product differentiation and regulatory environments.
  • Cost stability and regulatory approval favor a consistent financial profile.

FAQs

1. What are the primary applications of bentoquatam?
It is used as a skin barrier agent in sunscreens, chemical-resistant formulations, and occupational safety products to prevent chemical and UV damage.

2. How does regulatory status affect market potential?
Bentoquatam’s GRAS status facilitates market access in the U.S. and Europe, but changes in safety regulations can impact future growth.

3. Who are the main manufacturers of bentoquatam?
Major producers include BASF and several specialty chemical formulators licensing or manufacturing it for specific markets.

4. What are growth opportunities for bentoquatam?
Expanding into emerging markets, developing new formulations incorporating bentoquatam, and increasing industrial safety use are potential drivers.

5. How does competition impact bentoquatam's market share?
It faces competition from chemical UV filters with broader consumer appeal; however, its niche in chemical protection and occupational safety maintains specific demand.


References

[1] MarketsandMarkets. "Sunscreen Market by Type, Application, and Region," 2021.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.